- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANNABIS POLAND Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 23,600 | 0,00 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen / Kursziel: EUR 108 | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH 18.12.2024 / 15:36 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer... ► Artikel lesen | |
| HIGH TIDE | 2,870 | -0,69 % | High Tide Inc (2): High Tide to release fiscal 2024 results Jan. 29 | ||
| PHARMASGP | 26,000 | +2,36 % | EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.11.2024 / 12:00... ► Artikel lesen | |
| COMPASS PATHWAYS | 3,580 | -0,56 % | Compass Pathways plc: Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer | Newly created role of Chief Patient Officer reinforces Compass' vision of working to achieve broad and equitable access to COMP360, if approved
Compass Pathways plc (Nasdaq: CMPS) ("Compass"),... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,651 | +2,36 % | FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT IN RELATION TO THE 2025 H SHARE REPURCHASE PLAN AND THE 2025 A SHARE REPURCHASE PLAN | ||
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,035 | -13,58 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Inc. Provides Shareholder Progress Report | Burlington, Ontario--(Newsfile Corp. - December 11, 2024) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to present a progress... ► Artikel lesen | |
| SAVARA | 2,660 | 0,00 % | Savara Reports Third Quarter 2024 Financial Results and Provides Business Update | LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third... ► Artikel lesen | |
| EVOLUS | 13,500 | -0,74 % | Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company's Guidance | NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited... ► Artikel lesen | |
| ATYR PHARMA | 3,480 | +2,96 % | aTyr Pharma to Present at the LD Micro Main Event XVII in October | San Diego, California--(Newsfile Corp. - October 14, 2024) - aTyr Pharma, Inc. (NASDAQ: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines... ► Artikel lesen | |
| EVOKE PHARMA | 3,840 | 0,00 % | Evoke Pharma, Inc.: Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI | SOLANA BEACH, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 8,800 | -4,86 % | Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study | ||
| IMMUNOPRECISE ANTIBODIES | 0,670 | 0,00 % | What's Going On With ImmunoPrecise Antibodies Stock Wednesday? | ||
| STEVANATO GROUP | 20,400 | -3,77 % | Stevanato Group S.p.A. - 6-K, Report of foreign issuer | ||
| NIPPON KAYAKU | 7,700 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen |
Das Unternehmen CANNABIS POLAND SA kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,062 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNABIS POLAND SA finden Sie auf Wallstreet Online.
